Welcome to MCL!

This is the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions.

The MCL Consortium consists of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.

If you'd like to join us, fill out the registration form.


 

COMING UP SOON:

MCL 7th Semiannual Steering Committee Meeting

The MCL Consortium will hold its 7th Face-to-Face Steering Committee Meeting in Nashville, TN - April 24 - 27, 2019. More information coming soon.